AIM ImmunoTech Inc (AIM)
0.43
+0.01
(+2.38%)
USD |
NYAM |
Apr 23, 12:13
AIM ImmunoTech Cash from Operations (TTM): -21.27M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.27M |
| September 30, 2023 | -17.58M |
| June 30, 2023 | -16.88M |
| March 31, 2023 | -17.03M |
| December 31, 2022 | -16.11M |
| September 30, 2022 | -15.78M |
| June 30, 2022 | -14.27M |
| March 31, 2022 | -13.68M |
| December 31, 2021 | -13.96M |
| September 30, 2021 | -11.07M |
| June 30, 2021 | -10.61M |
| March 31, 2021 | -10.16M |
| December 31, 2020 | -10.37M |
| September 30, 2020 | -9.803M |
| June 30, 2020 | -9.358M |
| March 31, 2020 | -10.86M |
| December 31, 2019 | -9.067M |
| September 30, 2019 | -9.197M |
| June 30, 2019 | -9.629M |
| March 31, 2019 | -9.555M |
| December 31, 2018 | -10.64M |
| September 30, 2018 | -8.981M |
| June 30, 2018 | -7.885M |
| March 31, 2018 | -7.49M |
| December 31, 2017 | -7.941M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.283M |
| June 30, 2017 | -10.39M |
| March 31, 2017 | -9.33M |
| December 31, 2016 | -7.38M |
| September 30, 2016 | -8.592M |
| June 30, 2016 | -9.108M |
| March 31, 2016 | -12.84M |
| December 31, 2015 | -16.05M |
| September 30, 2015 | -16.77M |
| June 30, 2015 | -17.00M |
| March 31, 2015 | -15.33M |
| December 31, 2014 | -13.96M |
| September 30, 2014 | -13.19M |
| June 30, 2014 | -13.48M |
| March 31, 2014 | -13.94M |
| December 31, 2013 | -16.90M |
| September 30, 2013 | -18.60M |
| June 30, 2013 | -17.29M |
| March 31, 2013 | -17.32M |
| December 31, 2012 | -13.14M |
| September 30, 2012 | -11.20M |
| June 30, 2012 | -10.77M |
| March 31, 2012 | -9.943M |
| December 31, 2011 | -10.10M |
| September 30, 2011 | -8.89M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-21.27M
Minimum
Dec 2023
-9.067M
Maximum
Dec 2019
-12.98M
Average
-11.07M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |
| Armata Pharmaceuticals Inc | -47.42M |